Revolutionary Multiple Myeloma Drug, Linalidomide launched by Beacon By BPL|2016-08-31T07:21:41+00:00March 30th, 2016|Uncategorized|Comments Off on Revolutionary Multiple Myeloma Drug, Linalidomide launched by Beacon Share This Story, Choose Your Platform! facebooktwitterlinkedin About the Author: BPL Related Posts New Approach of Hepatitis C New Approach of Hepatitis C May 24th, 2016 Beacon Started Production of Hepatitis C Wonder Drug Daclatasvir Beacon Started Production of Hepatitis C Wonder Drug Daclatasvir May 7th, 2016 Annual Sales Conference of Beacon Pharmaceuticals Oncology Team Held in Thailand Annual Sales Conference of Beacon Pharmaceuticals Oncology Team Held in Thailand April 3rd, 2016 The 14th AGM of the Shareholders held on 20th December, 2015 The 14th AGM of the Shareholders held on 20th December, 2015 April 3rd, 2016 Quality Management System Quality Management System April 2nd, 2016
